Mechanism of Trifolin in Attenuating Hypertension-Induced Renal Cell Apoptosis via Modulation of the MAPK Signaling Pathway
Abstract
Objective
To investigate the potential therapeutic effects of trifolin on hypertension-induced renal injury, as well as the key targets and pathways involved.
Methods
The mRNA transcriptional profiles of peripheral blood clinical samples from hypertensive patients were analyzed using Gene Expression Omnibus (GEO), a high-throughput gene expression database. The network pharmacology method was employed to screen key targets of trifolin in treating hypertension-induced renal injury. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted. NRK-52E cells, a rat renal proximal tubular cell line, were used to construct an angiotensin Ⅱ (Ang Ⅱ)-stimulated cell model. Flow cytometry was performed to assess cell apoptosis rates and Western blotting was performed to determine the expression levels of apoptosis-related proteins, including Bax, Bcl-2, cleaved caspase-3, and caspase-3, and the phosphorylation and total protein levels of the key MAPK pathway proteins, including ERK, p38 MAPK, and JNK.
Results
Analysis of the dataset GSE75360 revealed that, compared with healthy controls, 3331 genes were upregulated and 3197 genes were downregulated in peripheral blood mononuclear cells of hypertensive patients. According to network pharmacology analysis, 472 potential targets of trifolin were identified, including CASP3 and MAPK1. Protein-protein interaction network analysis showed that these targets were closely associated with apoptosis regulatory signaling pathways. GO and KEGG pathway enrichment analyses indicated that trifolin was significantly enriched in pathways associated with negative regulation of apoptosis, apoptotic signaling pathways, and the MAPK signaling pathway. The in vitro experiments confirmed that, compared with the Ang Ⅱ group, trifolin intervention inhibited apoptosis in Ang Ⅱ-stimulated NRK-52E cells, suppressed the expression of Bax and cleaved caspase-3, promoted Bcl-2 expression, and inhibited the phosphorylation of p38 MAPK, ERK, and JNK (P < 0.05).
Conclusion
Trifolin may exert its protective effect against hypertension-induced renal injury by inhibiting Ang Ⅱ-induced NRK-52E cell apoptosis and regulating the MAPK signaling pathway, representing an important mechanism underlying its therapeutic action.
Keywords: Trifolin, Hypertensive nephropathy, Cell apoptosis, MAPK signaling pathway
Full Text:
PDFReferences
HAO X M, LIU Y, HAILAITI D. Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy. Front Immunol, 2024, 15: 1333170. doi: 10.3389/fimmu.2024.1333170.
ZHANG Y, ZHANG N, ZOU Y, et al. Deacetylation of Septin4 by SIRT2 (silent mating type information regulation 2 homolog-2) mitigates damaging of hypertensive nephropathy. Circ Res, 2023, 132(5): 601-624. doi: 10.1161/CIRCRESAHA.122.321591.
CHU Q, LI Y, WU J, et al. Oxysterol sensing through GPR183 triggers endothelial senescence in hypertension. Circ Res, 2024, 135(7): 708-721. doi: 10.1161/CIRCRESAHA.124.324722.
COSTANTINO V V, GIL LORENZO A F, BOCANEGRA V, et al. Molecular mechanisms of hypertensive nephropathy: renoprotective effect of Losartan through Hsp70. Cells, 2021, 10(11): 3146. doi: 10.3390/cells10113146.
FAN Y, CHENG J, YANG Q, et al. Sirt6-mediated Nrf2/HO-1 activation alleviates angiotensin Ⅱ-induced DNA DSBs and apoptosis in podocytes. Food Funct, 2021, 12(17): 7867-7882. doi: 10.1039/d0fo03467c.
DONG Z, DAI H, FENG Z, et al. Mechanism of herbal medicine on hypertensive nephropathy (review). Mol Med Rep, 2021, 23(4): 234. doi: 10.3892/mmr.2021.11873.
XIE T, BAI Z, CHEN Z, et al. Inhibition of ferroptosis ameliorates hypertensive nephropathy through p53/Nrf2/p21 pathway by Taohongsiwu decoction: based on network pharmacology and experimental validation. J Ethnopharmacol, 2023, 312: 116506. doi: 10. 1016/j.jep.2023.116506.
CHEN Z, PENG Y, YANG F, et al. Traditional Chinese medicine injections combined with antihypertensive drugs for hypertensive nephropathy: a network meta-analysis. Front Pharmacol, 2021, 12: 740821. doi: 10.3389/fphar.2021.740821.
WU X X, YE Y P, LEI Z D, et al. Icariin improves hypertensive renal fibrosis and injury through Cx32-Nox4 signaling pathway. Chin J Clin Pharmacol Ther, 2024, 29(8): 870-878. doi: 10.12092/j.issn.1009-2501. 2024.08.004.
WU W D, CHEN H, HUANG G Q. Mechanism of Uncaria and Mulberry Parasitism for the treatment of essential hypertension based on network pharmacology. Chin J Integr Med Cardio-Cerebrovasc Dis, 2024, 22(9): 1537-1546. doi: 10.12102/j.issn.1672-1349.2024.09.001.
KIM M J, KWON S B, KIM M S, et al. Trifolin induces apoptosis via extrinsic and intrinsic pathways in the NCI-H460 human non-small cell lung-cancer cell line. Phytomedicine, 2016, 23(10): 998-1004. doi: 10. 1016/j.phymed.2016.05.009.
REN C, ZHU Y, LI Q, et al. Lespedeza bicolor Turcz. Honey prevents inflammation response and inhibits ferroptosis by Nrf2/HO-1 pathway in DSS-induced human Caco-2 Cells. Antioxidants (Basel), 2024, 13(8): 900. doi: 10.3390/antiox13080900.
ZAI M J, CHEESMAN M J, COCK I E. Terminalia petiolaris A. Cunn ex Benth. Extracts have antibacterial activity and potentiate conventional antibiotics against β-lactam-drug-resistant bacteria. Antibiotics (Basel), 2023, 12(11): 1643. doi: 10.3390/antibiotics12111643.
ZHANG F, GUO Z, WU M, et al. Trifolin attenuates hypertension-mediated cardiac injury by inhibiting cardiomyocyte apoptosis: mechanistic insights and therapeutic potential. Eur J Pharmacol, 2024, 985: 177125. doi: 10.1016/j.ejphar.2024.177125.
LONG L, ZHANG X, WEN Y, et al. Qingda granule attenuates angiotensin Ⅱ-induced renal apoptosis and activation of the p53 pathway. Front Pharmacol, 2022, 12: 770863. doi: 10.3389/fphar.2021. 770863.
NGUYEN B A, ALEXANDER M R, HARRISON D G. Immune mechanisms in the pathophysiology of hypertension. Nat Rev Nephrol, 2024, 20(8): 530-540. doi: 10.1038/s41581-024-00838-w.
GUO Z, XIE Y, LIU H S, et al. Wogonoside attenuates hhypertension-induced renal injury through modulation of the MAPK signaling pathway: a mechanism study. J Sichuan Univ (Med Sci), 2025, 56(9): 41-50. doi: 10.12182/20250160103.
SHENG X, GUAN Y, MA Z, et al. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat Genet, 2021, 53(9): 1322-1333. doi: 10.1038/s41588-021-00909-9.
SONG Y, BAI Z, ZHANG Y, et al. Protective effects of endothelial progenitor cell microvesicles on Ang Ⅱ-induced rat kidney cell injury. Mol Med Rep, 2022, 25(1): 4. doi: 10.3892/mmr.2021.12520.
MEIJLES D N, CULL J J, MARKOU T, et al. Redox regulation of cardiac ASK1 (apoptosis signal-regulating kinase 1) controls p38-MAPK (mitogen-activated protein kinase) and orchestrates cardiac remodeling to hypertension. Hypertension, 2020, 76(4): 1208-1218. doi: 10.1161/HYPERTENSIONAHA.119.14556.
GUO M, ZHANG M, CAO X, et al. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension. Respir Res, 2022, 23(1): 6. doi: 10.1186/s12931-022-01927-9.
Refbacks
- There are currently no refbacks.
